YU41923B - Process for preparing a viral vaccine against influenza - Google Patents
Process for preparing a viral vaccine against influenzaInfo
- Publication number
- YU41923B YU41923B YU1265/80A YU126580A YU41923B YU 41923 B YU41923 B YU 41923B YU 1265/80 A YU1265/80 A YU 1265/80A YU 126580 A YU126580 A YU 126580A YU 41923 B YU41923 B YU 41923B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- preparing
- vaccine against
- against influenza
- viral vaccine
- viral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3923679A | 1979-05-15 | 1979-05-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
YU126580A YU126580A (en) | 1983-12-31 |
YU41923B true YU41923B (en) | 1988-02-29 |
Family
ID=21904398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU1265/80A YU41923B (en) | 1979-05-15 | 1980-05-13 | Process for preparing a viral vaccine against influenza |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0019218B2 (xx) |
JP (1) | JPS55153723A (xx) |
AR (1) | AR220838A1 (xx) |
AT (1) | ATE16454T1 (xx) |
AU (1) | AU535804B2 (xx) |
CA (1) | CA1122527A (xx) |
DE (1) | DE3071225D1 (xx) |
DK (1) | DK154749C (xx) |
ES (1) | ES491517A0 (xx) |
IL (1) | IL60063A0 (xx) |
NO (1) | NO801443L (xx) |
RO (1) | RO79525B (xx) |
YU (1) | YU41923B (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6146873A (en) * | 1994-11-10 | 2000-11-14 | Baxter Aktiengesellschaft | Production of orthomyxoviruses in monkey kidney cells using protein-free media |
US5753489A (en) * | 1994-11-10 | 1998-05-19 | Immuno Ag | Method for producing viruses and vaccines in serum-free culture |
US5698433A (en) * | 1994-11-10 | 1997-12-16 | Immuno Ag | Method for producing influenza virus and vaccine |
EP1213030B1 (en) * | 1994-11-10 | 2009-04-22 | Baxter Healthcare SA | Method for producing biologicals in protein-free culture |
WO1996015232A1 (en) * | 1994-11-16 | 1996-05-23 | St. Jude Children's Research Hospital | Novel replication process |
DE19612967A1 (de) * | 1996-04-01 | 1997-10-02 | Behringwerke Ag | Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren |
DE19612966B4 (de) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
DE10144906B4 (de) | 2001-09-12 | 2013-11-28 | Novartis Vaccines And Diagnostics Gmbh | Verfahren zur großtechnischen Herstellung von Impfstoffen |
US6830917B2 (en) | 2001-12-10 | 2004-12-14 | Baxter Healthcare S.A. | Method of isolation and purification of trypsin from pronase protease and use thereof |
EP1807116B1 (en) | 2004-11-03 | 2015-05-06 | Novartis Vaccines and Diagnostics, Inc. | Influenza vaccination |
EP2022849A4 (en) | 2006-05-11 | 2010-10-06 | Chemo Sero Therapeut Res Inst | METHOD FOR PROLIFERATION OF INFLUENZA VIRUS |
US8506966B2 (en) | 2008-02-22 | 2013-08-13 | Novartis Ag | Adjuvanted influenza vaccines for pediatric use |
TW201012930A (en) * | 2008-06-16 | 2010-04-01 | Intervet Int Bv | Method of replicating viruses in suspension |
CA2751379C (en) | 2009-02-10 | 2018-06-12 | Novartis Ag | Influenza vaccines with reduced amounts of squalene |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2262962B1 (xx) * | 1974-03-05 | 1977-11-04 | Science Union & Cie |
-
1980
- 1980-04-22 CA CA350,366A patent/CA1122527A/en not_active Expired
- 1980-04-30 AR AR280860A patent/AR220838A1/es active
- 1980-05-08 DE DE8080102525T patent/DE3071225D1/de not_active Expired
- 1980-05-08 EP EP80102525A patent/EP0019218B2/de not_active Expired - Lifetime
- 1980-05-08 AT AT80102525T patent/ATE16454T1/de not_active IP Right Cessation
- 1980-05-09 AU AU58244/80A patent/AU535804B2/en not_active Expired
- 1980-05-13 YU YU1265/80A patent/YU41923B/xx unknown
- 1980-05-13 RO RO101109A patent/RO79525B/ro unknown
- 1980-05-13 IL IL60063A patent/IL60063A0/xx unknown
- 1980-05-13 JP JP6235780A patent/JPS55153723A/ja active Granted
- 1980-05-14 NO NO801443A patent/NO801443L/no unknown
- 1980-05-14 ES ES491517A patent/ES491517A0/es active Granted
- 1980-05-14 DK DK212580A patent/DK154749C/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3071225D1 (en) | 1985-12-19 |
DK154749B (da) | 1988-12-19 |
AU535804B2 (en) | 1984-04-05 |
DK154749C (da) | 1989-05-16 |
DK212580A (da) | 1980-11-16 |
EP0019218B1 (de) | 1985-11-13 |
RO79525B (ro) | 1984-09-30 |
ES8104405A1 (es) | 1981-04-01 |
ES491517A0 (es) | 1981-04-01 |
EP0019218A3 (en) | 1981-03-25 |
JPH0124769B2 (xx) | 1989-05-15 |
EP0019218A2 (de) | 1980-11-26 |
AR220838A1 (es) | 1980-11-28 |
CA1122527A (en) | 1982-04-27 |
IL60063A0 (en) | 1980-07-31 |
RO79525A (ro) | 1984-07-17 |
EP0019218B2 (de) | 1995-03-01 |
JPS55153723A (en) | 1980-11-29 |
NO801443L (no) | 1980-11-17 |
ATE16454T1 (de) | 1985-11-15 |
AU5824480A (en) | 1980-11-20 |
YU126580A (en) | 1983-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT77977B (en) | Process for preparing a coupled h.influenza type b vaccine | |
PT71926B (en) | Process for preparing a liquid vaccine comprising a stabilizer | |
EG13530A (en) | A process for preparing imidazolderivates | |
PT70446A (en) | Process for preparation a aqueous lubrificant | |
YU126580A (en) | Process for preparing a viral vaccine against influenza | |
PT71044A (en) | A process for preparing mercaptoacyldipeptides | |
PT68831A (en) | Process for the preparation of a pneumococcal vaccine | |
PT70452A (en) | Process for preparing a spiro-polycyclicimidazolidinedionederivative | |
DE3064479D1 (en) | Process for preparing a b30-threonine insulin | |
HU179290B (en) | Process for preparing vaccine against poultry pest | |
EP0004793A3 (en) | Process for preparing 2-aminopyrimidones, intermediate 2-nitroaminopyrimidones and a process for their preparation | |
DE2962494D1 (en) | A process for preparing lysergol derivatives | |
DE3377972D1 (en) | A process for producing a hepatitis b infection preventing vaccine | |
ZA804107B (en) | A process for preparing aldehydes | |
GB2065473B (en) | Process for producing hepatitis b vaccine | |
PT69522A (en) | Process for preparing a quinazoline derivative | |
DE3063984D1 (en) | A process for preparing a diarylamine | |
IL58947A (en) | Vaccines against viral illnesses | |
GB2065119B (en) | Process for preparing a mycophenolic acid derivative | |
PT67632A (en) | Process for the preparation of a respiratory syncytial vaccine | |
CH611518A5 (en) | Process for the preparation of a virus subunit vaccine | |
PT71822B (en) | Process for preparing vaccine for dental caries | |
PH14990A (en) | Process for producing a vaccine | |
YU103079A (en) | Process for preparing a trisazo-dye | |
GB2048066B (en) | Rabies vaccine |